Altamira Therapeutics Ltd... (CYTO)
0.30
0.00 (0.00%)
At close: Jan 16, 2025, 9:00 PM
Altamira Therapeutics Revenue
Altamira Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending June 30, 2023, Altamira Therapeutics generated $52.73K in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
10
Market Cap
1.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 0 | -100.00% |
| Dec 31, 2022 | 305.62K | +378.41% |
| Dec 31, 2021 | 63.88K | -63.39% |
| Dec 31, 2020 | 174.47K | n/a |